Report Detail
Global Parkinson's Disease (PD) Drugs Market Research Report 2019
- RnM3130648 |
- 15 March, 2019 |
- Global |
- 108 Pages |
- QYResearch |
- Pharma & Healthcare
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.
The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain traction in the market for parkinsons drugs throughout the estimated period.
The global Parkinson's Disease (PD) Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Parkinson's Disease (PD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease (PD) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Segment by Application
Hospital
Family
Table of Contents
Executive Summary
1 Parkinson's Disease (PD) Drugs Market Overview
- 1.1 Product Overview and Scope of Parkinson's Disease (PD) Drugs
- 1.2 Parkinson's Disease (PD) Drugs Segment by Type
- 1.2.1 Global Parkinson's Disease (PD) Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Dopamine Agonist
- 1.2.3 Monoamine Oxidase Inhibitors
- 1.2.4 Acetylcholinesterase Inhibitors
- 1.2.5 Glutamate Inhibitors
- 1.3 Parkinson's Disease (PD) Drugs Segment by Application
- 1.3.1 Parkinson's Disease (PD) Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Family
- 1.4 Global Parkinson's Disease (PD) Drugs Market by Region
- 1.4.1 Global Parkinson's Disease (PD) Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Parkinson's Disease (PD) Drugs Market Size
- 1.5.1 Global Parkinson's Disease (PD) Drugs Revenue (2014-2025)
- 1.5.2 Global Parkinson's Disease (PD) Drugs Production (2014-2025)
2 Global Parkinson's Disease (PD) Drugs Market Competition by Manufacturers
- 2.1 Global Parkinson's Disease (PD) Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Parkinson's Disease (PD) Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Parkinson's Disease (PD) Drugs Production Sites, Area Served, Product Types
- 2.5 Parkinson's Disease (PD) Drugs Market Competitive Situation and Trends
- 2.5.1 Parkinson's Disease (PD) Drugs Market Concentration Rate
- 2.5.2 Parkinson's Disease (PD) Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Parkinson's Disease (PD) Drugs Production Market Share by Regions
- 3.1 Global Parkinson's Disease (PD) Drugs Production Market Share by Regions
- 3.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Parkinson's Disease (PD) Drugs Production
- 3.4.1 North America Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Parkinson's Disease (PD) Drugs Production
- 3.5.1 Europe Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Parkinson's Disease (PD) Drugs Production (2014-2019)
- 3.6.1 China Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Parkinson's Disease (PD) Drugs Production (2014-2019)
- 3.7.1 Japan Parkinson's Disease (PD) Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Parkinson's Disease (PD) Drugs Consumption by Regions
- 4.1 Global Parkinson's Disease (PD) Drugs Consumption by Regions
- 4.2 North America Parkinson's Disease (PD) Drugs Consumption (2014-2019)
- 4.3 Europe Parkinson's Disease (PD) Drugs Consumption (2014-2019)
- 4.4 China Parkinson's Disease (PD) Drugs Consumption (2014-2019)
- 4.5 Japan Parkinson's Disease (PD) Drugs Consumption (2014-2019)
5 Global Parkinson's Disease (PD) Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Parkinson's Disease (PD) Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Parkinson's Disease (PD) Drugs Price by Type (2014-2019)
- 5.4 Global Parkinson's Disease (PD) Drugs Production Growth by Type (2014-2019)
6 Global Parkinson's Disease (PD) Drugs Market Analysis by Applications
- 6.1 Global Parkinson's Disease (PD) Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Parkinson's Disease (PD) Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Parkinson's Disease (PD) Drugs Business
- 7.1 Boehringer Ingelheim
- 7.1.1 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.1.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 GlaxoSmithKline
- 7.2.1 GlaxoSmithKline Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.2.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Novartis
- 7.3.1 Novartis Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.3.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.3.3 Novartis Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Teva Pharmaceutical Industries
- 7.4.1 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.4.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 AbbVie
- 7.5.1 AbbVie Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.5.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.5.3 AbbVie Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Abital Pharma
- 7.6.1 Abital Pharma Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.6.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Addex Therapeutics
- 7.7.1 Addex Therapeutics Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.7.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Biogen
- 7.8.1 Biogen Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.8.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.8.3 Biogen Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Eisai
- 7.9.1 Eisai Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.9.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.9.3 Eisai Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Eli Lilly
- 7.10.1 Eli Lilly Parkinson's Disease (PD) Drugs Production Sites and Area Served
- 7.10.2 Parkinson's Disease (PD) Drugs Product Introduction, Application and Specification
- 7.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 F. Hoffmann-La Roche
- 7.12 H. Lundbeck
- 7.13 Impax Laboratories
- 7.14 Kyowa Hakko Kirin
- 7.15 Otsuka Pharmaceutical
- 7.16 Pfizer
8 Parkinson's Disease (PD) Drugs Manufacturing Cost Analysis
- 8.1 Parkinson's Disease (PD) Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Parkinson's Disease (PD) Drugs
- 8.4 Parkinson's Disease (PD) Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Parkinson's Disease (PD) Drugs Distributors List
- 9.3 Parkinson's Disease (PD) Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Parkinson's Disease (PD) Drugs Market Forecast
- 11.1 Global Parkinson's Disease (PD) Drugs Production, Revenue Forecast
- 11.1.1 Global Parkinson's Disease (PD) Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Parkinson's Disease (PD) Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Parkinson's Disease (PD) Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Parkinson's Disease (PD) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Parkinson's Disease (PD) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Parkinson's Disease (PD) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Parkinson's Disease (PD) Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Parkinson's Disease (PD) Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Parkinson's Disease (PD) Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Parkinson's Disease (PD) Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Parkinson's Disease (PD) Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Parkinson's Disease (PD) Drugs Consumption Forecast (2019-2025)
- 11.4 Global Parkinson's Disease (PD) Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Parkinson's Disease (PD) Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Parkinson's Disease (PD) Drugs . Industry analysis & Market Report on Parkinson's Disease (PD) Drugs is a syndicated market report, published as Global Parkinson's Disease (PD) Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Parkinson's Disease (PD) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
